Introduction of Fosaprpit 150 mg Injection

• Fosaprpit 150 mg Injection is a drug used to prevent nausea and vomiting. It is used, along with other antiemetic medicines, to prevent nausea and vomiting caused by chemotherapy in adults and pediatric patients as young as 6 months of age.

  Fosaprpit 150 mg Injection may cause some common adverse effects, such as fatigue, diarrhoea, neutropenia, anaemia, peripheral neuropathy, neutropenia, dyspepsia, pain and urinary tract infection. It is also important to follow Fosaprpit 150 mg's instructions, including recommended dosage and timing, and any dietary or lifestyle restrictions. Do not hesitate to contact your doctor if you have any questions or concerns about the medicine or its side effects.

  Before taking this Fosaprpit 150 mg, tell your doctor about any medical problems such as if you have any existing medical conditions such as liver or kidney disease or any other medical problems and also inform if you have recently taken any other medicines, vitamins, herbs, etc., or if you are taking this Fosaprpit 150 mg. Please make sure you tell your doctor about this.

  Fosaprpit 150 mg Injection is supplied as a powder to be mixed with liquid and given intravenously (into a vein) by a doctor or nurse in a health care facility. It is best to take your doses at regular intervals. Do not stop taking this medicine suddenly without telling your doctor or health care professional. If you miss a dose, take it as soon as you remember and finish the treatment, even if you feel better. Your doctor or health care professional may want to monitor your LFTs while taking this medicine.
  

Uses of Fosaprpit 150 mg Injection

• Prevention of nausea and vomiting: Fosaprpit Injection is used to help prevent nausea and vomiting caused by chemotherapy.
  

Benefits of Fosaprpit 150 mg Injection

• Fosaprpit 150 mg Injection is a highly effective solution for nausea and vomiting often associated with chemotherapy. This product successfully prevents these distressing symptoms by inhibiting the activity of substance P, a neurotransmitter responsible for triggering the vomiting reflex. As nausea and vomiting are common side effects of chemotherapy, their impact on a patient's quality of life can be significant. However, with the help of Fosaprpit 150 mg, patients can experience relief and an overall improvement in their well-being. Not only does it help patients recover more comfortably from cancer treatments such as radiotherapy or chemotherapy, but it has also been shown to be very effective in preventing nausea and vomiting following surgery (only in adults). It is important to note that Fosaprpit 150 mg should only be administered by a healthcare professional and not by the patient themselves.
  

Side Effects of Fosaprpit 150 mg Injection

• As with all medicines, Fosaprpit Injection may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
  

Most Common Side Effects of Fosaprpit 150 mg Injection

• • Tiredness
  • Weakness
  • Headache
  • Heartburn
  • Numbness, weakness, tingling, or pain in legs or arms
  • Diarrhoea
  • Indigestion
  • Fever
  • Redness, itching, hardness, swelling, or pain at the injection site

Common Side Effects of Fosaprpit 150 mg Injection

• • Painful or frequent urination
  • Trouble swallowing or breathing
  • Low blood cell count
  • Unusual bleeding
  • Fast or weak heartbeats
  • ​Hives
  • Itching
  • Rash
  • Skin Sores or Peeling
  • Dizziness
  • Swelling
    

How to Use Fosaprpit 150 mg Injection?

• Fosaprpit 150 mg Injection administered intravenously (into a vein) comes as a powder and is to be mixed with liquid by a health care professional, nurse or doctor in a medical facility. It is given for 1 time on the first day of a cancer chemotherapy treatment cycle. The frequency and dosage of Fosaprpit Injection injection is decided by your health care professional or doctor. You should inform your health care, professional or doctor if you face any serious side effects.
  

How Fosaprpit 150 mg Injection Works?

• Fosaprpit 150 mg Injection is a selective NK-1 receptor antagonist, which means that it helps block the action of neurokinin. It prevents acute and delayed nausea and vomiting in patients following certain chemotherapies.
  

Safety Advices Fosaprpit 150 mg Injection

Kidney

Safe

Patients with kidney disease can safely use Fosaprpit 150 mg. No dose adjustment of Fosaprpit 150 mg is necessary.

Alcohol

Unsafe

Avoiding alcohol consumption is advised when taking Fosaprpit 150 mg Injection to reduce the risk of liver damage. It is best to refrain from drinking alcohol while on any medication.

Driving

Unsafe

The usage of Fosaprpit 150 mg Injection can lead to symptoms like dizziness, fatigue, and impaired concentration and coordination, which can potentially compromise your driving skills. To ensure your safety, it is crucial to adhere to your doctor's guidance and take necessary precautions, such as refraining from driving or operating heavy machinery if you experience any of these side effects caused by Fosaprpit 150 mg.

Liver

Use with Caution

Patients with liver disease should exercise caution when using Fosaprpit 150 mg Injection. It is crucial for individuals with liver disease to closely observe their liver function while using Fosaprpit 150 mg and promptly inform their physician of any abnormal symptoms or changes in liver function. Adjustments to the dosage of Fosaprpit Injection may be necessary for patients with liver disease.

Breastfeeding

Unsafe

Breastfeeding while on Fosaprpit 150 mg is not recommended as it may harm the infant. Consult your doctor to discuss the potential risks and benefits of continuing to breastfeed while taking Fosaprpit 150 mg Injection. Your doctor can help you make an informed decision for the health of both you and your baby.

Pregnancy

Safe

There is a lack of sufficient and properly conducted studies on pregnant women. The use of Fosaprpit 150 mg Injection during pregnancy should only be considered if the potential benefits outweigh the potential risks to both the mother and the fetus.